Topic: Kidney Cancer

AFP Global Edition | 2010-01-06 18:10:21
<div><p>A new probe into the inherited causes of the commonest form of kidney cancer has confirmed the culprit role of a single gene but also shed light on more complex disease-causing machinery, scientists said on Wednesday.</p><p>A trawl through the DNA of 101 people diagnosed with clear cell ...
Continue reading... 
Reuters US Online Report Health News | 2010-01-06 17:38:40
<div><p>LONDON (Reuters) - The more scientists look, the more complex cancer seems to become.</p><p>British scientists said on Wednesday they had found a batch of new gene mutations linked to kidney cancer, suggesting even this apparently "straightforward" cancer type can be divided into subtypes requiring tailored treatment.</p ...
Continue reading... 
AP News | 2009-10-01 14:57:08
<div id="subtitle">FDA notes liver damage risks with GlaxoSmithKline's kidney cancer drug</div><div><p>Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.</p><p>London-based Glaxo wants the Food and ...
Continue reading... 
Reuters US Online Report Health News | 2009-10-01 14:47:36
<div><p>WASHINGTON (Reuters) - The U.S. Food and Drug Administration's review staff expressed doubts that GlaxoSmithKline Plc's experimental kidney cancer drug Votrient should be approved given concerns about liver injury, documents released on Thursday said.</p><p>Votrient, also known by its chemical name pazopanib, aims to treat advanced ...
Continue reading... 
Cancer widow 'was sold false hope'

Brisbane Times, Australia | 2010-03-12 15:32:45

Friday's standouts

MarketWatch | 2010-03-12 09:48:53

John Baron MP attends Kidney Cancer reception

UK Politics | 2010-03-12 06:28:20

Cambridge drug maker Aveo’s stock market debut a downer

Boston Herald | 2010-03-12 00:44:14

Pfizer Sees Some Disappointing Study Results

Blogging Stocks | 2010-03-12 11:15:27

loading
loading
loading